Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
Innovations in Actinic Keratosis
Rawlings E Lyle1, Linh H Tran1, Daniel B Eisen2
1Department of Dermatology, University of California, Davis School of Medicine, 4610 X Street, Sacramento, CA 95817, USA.
Recent advancements in actinic keratosis (AK) management include new therapies and understanding of disease progression. Personalized, technology-enhanced approaches aim to improve patient outcomes and prevent skin cancer.
Area of Science:
- Dermatology and Oncology
- Molecular Biology
- Microbiology
Background:
- Actinic keratosis (AK) is a common precursor to squamous cell carcinoma.
- Effective management and early detection are crucial for preventing cancer progression.
Purpose of the Study:
- To review recent therapeutic breakthroughs and pathophysiological discoveries in AK management.
- To explore advances in photodynamic therapy and new topical treatments.
- To detail genomic and transcriptomic pathways from AK to squamous cell carcinoma, including microbiome roles.
Main Methods:
- Literature review of recent studies on AK management.
- Analysis of therapeutic innovations and diagnostic improvements.
- Examination of molecular pathways and microbiome influence.
Main Results:
- Highlighting novel treatments and improved diagnostic strategies.
- Elucidating the genomic and transcriptomic landscape of AK progression.
- Emphasizing the role of the cutaneous microbiome in AK development.
Conclusions:
- Current insights support personalized, technology-enhanced AK treatment strategies.
- Improved patient care and adherence are key to better outcomes.
- Preventing AK progression to squamous cell carcinoma remains a primary goal.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
Renewal of Skin Epidermal Stem Cells
Tumor Immunotherapy
iPS Cell Differentiation

